一个全自动化的,专家感知图像质量评估系统,用于全身[18F]FDG PET/CT
Cong Zhang1,2, Xin Gao3, Xuebin Zheng4
1Medical School of Chinese PLA, Beijing, China.
EJNMMI research
|April 18, 2025
概括
一个新的深度学习系统准确地评估临床[18F]FDG PET/CT图像质量,与专家评估相匹配. 这种自动化工具为多中心研究提供客观,标准化的质量控制.
科学领域:
- 医疗成像医学成像
- 人工智能的人工智能
- 放射化学 放射化学是指辐射化学.
背景情况:
- 临床PET/CT图像质量对于诊断和研究至关重要.
- 目前的质量评估方法缺乏自动化,并且是特定于区域的.
- 需要对全身PET/CT质量进行自动化,可解释的评估.
研究的目的:
- 开发基于深度学习的专家感知图像质量评估 (IQA) 系统.
- 自动化对临床[18F]FDG PET/CT图像质量的评估.
- 为多中心IQA提供一个客观和标准化的工具.
主要方法:
- 718个全身[18F]FDG PET/CT扫描的回顾性分析.
- 自动切片选择和基于专家的主观评分.
- 在MANIQA框架内使用视觉转换器和注意力机制开发了深度学习模型.
- 对模型性能与专家评估 (斯皮尔曼的 ρ,ICC) 和ROC曲线进行统计分析.
主要成果:
- IQA模型实现了高精度:PET的0.832和CT切片水平质量的0.902.
- 与专家评分有很强的一致性:斯皮尔曼的 ρ 为 0.891 (PET) 和 0.624 (CT).
- 优异的评价者之间的可靠性:ICC为0.953 (PET) 和0.92 (CT).
- 对于PET IQA的高分辨性性能 (胸部和腹部区域AUC≥0.88).
结论:
- 自动化IQA系统提供了对临床图像质量的强大,客观的评估.
- 该系统显示出作为一个公正的,专家级工具的潜力.
- 能够实现标准化的多中心临床IQA.
相关概念视频
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
39
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
39
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)

